Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Jean‐Pierre Gérard, Laurent Bedenne, Thierry Conroy et al.|Journal of Clinical Oncology|2006Cited by 1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upMichel Ducreux, Dirk Arnold, Caroline Caramella et al.|Annals of Oncology|2015Cited by 1.3k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal CancerMarc Peeters, Jennifer Gansert, Timothy Price et al.|Journal of Clinical Oncology|2010Cited by 1k
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upArndt Vogel, Michel Ducreux|Annals of Oncology|2022Cited by 611
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialÉtienne Garin, Lambros Tselikas, Boris Guiu et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 602